BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32871034)

  • 1. Percutaneous microwave ablation of renal masses in a UK cohort.
    John JB; Anderson M; Dutton T; Stott M; Crundwell M; Llewelyn R; Gemmell A; Bufacchi R; Spiers A; Campain N
    BJU Int; 2021 Apr; 127(4):486-494. PubMed ID: 32871034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
    Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
    Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
    Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
    Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
    Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microwave ablation of cT1a renal cell carcinoma: oncologic and functional outcomes at a single center.
    Wilcox Vanden Berg RN; Calderon LP; LaRussa S; Enobakhare O; Craig K; Del Pizzo J; McClure TD
    Clin Imaging; 2021 Aug; 76():199-204. PubMed ID: 33964597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
    Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
    Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
    Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G
    Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage surgery after energy ablation for renal masses.
    Karam JA; Wood CG; Compton ZR; Rao P; Vikram R; Ahrar K; Matin SF
    BJU Int; 2015 Jan; 115(1):74-80. PubMed ID: 24656119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma.
    Yu J; Zhang G; Liang P; Yu XL; Cheng ZG; Han ZY; Zhang X; Dong J; Li QY; Mu MJ; Li X
    Abdom Imaging; 2015 Oct; 40(8):3248-56. PubMed ID: 26288264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients.
    Yu J; Zhang X; Liu H; Zhang R; Yu X; Cheng Z; Han Z; Liu F; Hao G; Mu MJ; Liang P
    Radiology; 2020 Mar; 294(3):698-706. PubMed ID: 31961239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery.
    Shapiro DD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Jarrard DF; Richards KA; Downs TM; Allen GO; Nakada SY; Abel EJ
    Urology; 2020 Jan; 135():88-94. PubMed ID: 31585198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma: evaluating the performance of nephrometry scores.
    Efthymiou E; Velonakis G; Charalampopoulos G; Mazioti A; Brountzos E; Kelekis N; Filippiadis D
    Eur Radiol; 2023 Nov; 33(11):7388-7397. PubMed ID: 37318604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Microwave Ablation Versus Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma: A Propensity-Matched Cohort Study Focusing Upon Long-Term Follow-Up of Oncologic Outcomes.
    Chlorogiannis DD; Kratiras Z; Efthymiou E; Moulavasilis N; Kelekis N; Chrisofos M; Stravodimos K; Filippiadis DK
    Cardiovasc Intervent Radiol; 2024 May; 47(5):573-582. PubMed ID: 38561521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results.
    Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Zhang X; Dong J; Mu MJ; Li X; Wang XH
    Radiology; 2014 Mar; 270(3):880-7. PubMed ID: 24475805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study.
    Nielsen TK; Lagerveld BW; Keeley F; Lughezzani G; Sriprasad S; Barber NJ; Hansen LU; Buffi NM; Guazzoni G; van der Zee JA; Ismail M; Farrag K; Emara AM; Lund L; Østraat Ø; Borre M
    BJU Int; 2017 Mar; 119(3):390-395. PubMed ID: 27488479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
    Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of Microwave Ablation Into a Renal Ablation Practice: Valuable Lessons Learned.
    Thompson SM; Schmitz JJ; Thompson RH; Weisbrod AJ; Welch BT; Viers BR; Hannon JD; Schmit GD; Atwell TD; Kurup AN
    AJR Am J Roentgenol; 2018 Dec; 211(6):1381-1389. PubMed ID: 30247980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound.
    Chen CN; Liang P; Yu J; Yu XL; Cheng ZG; Han ZY; Liu FY; Li X
    Int J Hyperthermia; 2016 Sep; 32(6):607-13. PubMed ID: 27269816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.